drugset / Trial / NCT02452801
Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic Function
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the effect of various degrees of hepatic function on the pharmacokinetics and safety of ALKS 5461.
Timeline
- Start
- 2015-05
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALKS 5461 | Unknown | — | Oral |
Indications
No indication recorded.